The funding will be used to complete the Phase II/III trial of ulviprubart, and to support commercial launch preparation.

We recently compiled a list of the Top 10 Must-See AI News Updates for Investors. In this article, we are going to take a ...

GlobalData’s Revati Tatake discussed key trends in biopharma which are set to have an impact in 2025 and beyond.

We recently published a list of the 12 Best Long-Term Growth Stocks to Buy Now. In this article, we are going to take a look ...

Sarah O’Keeffe recounts her fulfilling career path with Eli Lilly from employee to Senior Vice President, Product Research ...

Released on Friday, February 7, the January jobs report showed resilience in the labor market with higher-than-expected wage ...